These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6130752

  • 1. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
    Marks IM, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stern RS.
    Arch Gen Psychiatry; 1983 Feb; 40(2):153-62. PubMed ID: 6130752
    [Abstract] [Full Text] [Related]

  • 2. Two-year follow-up of agoraphobics after exposure and imipramine.
    Cohen SD, Monteiro W, Marks IM.
    Br J Psychiatry; 1984 Mar; 144():276-81. PubMed ID: 6367875
    [Abstract] [Full Text] [Related]

  • 3. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.
    Lelliott PT, Marks IM, Monteiro WO, Tsakiris F, Noshirvani H.
    J Nerv Ment Dis; 1987 Oct; 175(10):599-605. PubMed ID: 3309186
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M, Michelson L.
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [Abstract] [Full Text] [Related]

  • 6. Comparison of short-term treatment regimens in phobic patients: a preliminary report.
    Zitrin CM, Klein DF, Lindemann C, Tobak P, Rock M, Kaplan JE, Ganz VH.
    Proc Annu Meet Am Psychopathol Assoc; 1976 Mar; (64):233-50. PubMed ID: 4791
    [No Abstract] [Full Text] [Related]

  • 7. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M, Michelson L.
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined pharmacological and behavioral treatment for agoraphobia.
    Telch MJ, Agras WS, Taylor CB, Roth WT, Gallen CC.
    Behav Res Ther; 1985 Sep; 23(3):325-35. PubMed ID: 2860892
    [No Abstract] [Full Text] [Related]

  • 11. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF, Ross DC, Cohen P.
    Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
    [Abstract] [Full Text] [Related]

  • 12. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M, Perel J.
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [Abstract] [Full Text] [Related]

  • 13. Clinically significant improvement in agoraphobia research.
    Mavissakalian M.
    Behav Res Ther; 1986 Sep; 24(3):369-70. PubMed ID: 2873811
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of agoraphobia with group exposure in vivo and imipramine.
    Zitrin CM, Klein DF, Woerner MG.
    Arch Gen Psychiatry; 1980 Jan; 37(1):63-72. PubMed ID: 6101535
    [Abstract] [Full Text] [Related]

  • 16. Safety-signal therapy in agoraphobics: a preliminary test.
    Sartory G, Master D, Rachman S.
    Behav Res Ther; 1989 Jan; 27(2):205-9. PubMed ID: 2930448
    [Abstract] [Full Text] [Related]

  • 17. Agoraphobics and social phobics: differences in background factors, syndrome profiles and therapeutic response.
    Persson G, Nordlund CL.
    Acta Psychiatr Scand; 1985 Feb; 71(2):148-59. PubMed ID: 2858149
    [Abstract] [Full Text] [Related]

  • 18. Generalization of therapeutic changes in agoraphobia: the role of perceived self-efficacy.
    Williams SL, Kinney PJ, Falbo J.
    J Consult Clin Psychol; 1989 Jun; 57(3):436-42. PubMed ID: 2567745
    [Abstract] [Full Text] [Related]

  • 19. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR, Perel JM.
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [Abstract] [Full Text] [Related]

  • 20. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.